ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kamada and Kedrion to develop immunoglobulin product for Covid-19
April 30, 2020Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human plasma-derived polyclonal immunoglobulin (IgG) product for potential Covid-19 treatment. -
Kedrion Biopharma to Develop Plasma-based Treatment for COVID-19
April 10, 2020Kedrion Biopharma has started the development of a plasma-derived therapy for treating the COVID-19 virus that could make it available to patients in as little as three to six months.
Pharma Sources Insight January 2025
